XML 48 R30.htm IDEA: XBRL DOCUMENT v3.23.4

Stock-Based Compensation (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2023

Dec. 31, 2022

Stock-Based Compensation [Abstract]

Schedule of Table Summarizes the Activity

The following table summarizes the activity in the shares available for grant under the Plans during the nine months ended September 30, 2023 (in thousands, except exercise price):

						Options Outstanding
										Weighted
		Shares								Average
		Available				Number of				Exercise
		for Grant				Shares				Prices
Balance as of December 31, 2022			39				37			$	132.80
RSUs granted			(2	)			—			$	—
RSUs cancelled and returned to the Plans			1				—			$	—
Options cancelled			—				—			$	270.40
Balance as of March 31, 2023			38				37			$	131.20
RSUs granted			(2	)			—			$	—
RSUs cancelled and returned to the Plans			2				—			$	—
Options cancelled			—				—			$	116.80
Balance as of June 30, 2023			38				37			$	131.20
RSUs cancelled and returned to the Plans			1				—			$	—
Options cancelled			—				(1	)		$	493.60
Balance as of September 30, 2023			39				36			$	122.80

The following table summarizes the activity in the shares available for grant under the Plans during the years ended December 31, 2021 and December 31, 2022 (in thousands, except exercise price):

						Options outstanding
										Weighted
		Shares								Average
		Available				Number of				Exercise
		for Grant				Shares				Prices
Balance as of January 1, 2021			9				26			$	101.60
Additional shares authorized under the Plans			78				—				—
RSUs granted			(1	)			—				—
Options granted			(10	)			10			$	120.00
Options exercised			—				—			$	68.80
Options cancelled and returned to the Plans			—				(1	)		$	108.80
Effect of business combination			—				4			$	414.00
Balance as of December 31, 2021			76				39			$	139.60
RSUs granted			(44	)			—			$	—
RSUs cancelled and returned to the Plans			7				—			$	—
Options cancelled			—				(2	)		$	250.80
Balance as of December 31, 2022			39				37			$	132.80

Schedule of Summary of Rsu Activity Under Plans

A summary of RSU activity under the Plans is presented below (in thousands, except for fair value):

		Number of Shares				Weighted Average Grant-Date Fair Value
Non-vested shares as of December 31, 2022			27			$	82.40
Granted			2			$	39.60
Vested			(2	)		$	82.80
Non-vested shares as of March 31, 2023			27			$	79.20
Granted			2			$	20.80
Vested			(5	)		$	86.40
Cancels			—			$	86.00
Non-vested shares as of June 30, 2023			24			$	79.20
Vested			(1	)		$	73.20
Cancels			—			$	86.00
Non-vested shares as of September 30, 2023			23			$	73.20

A summary of RSU activity under the Plans is presented below (in thousands, except for fair value):

						Weighted
						Average
		Number of				Grant-Date
		Shares				Fair Value
Non-vested shares as of December 31, 2020			—			$	0.00
Granted			1			$	202.80
Vested			(1	)		$	168.40
Effect of business combination			2			$	168.40
Non-vested shares as of December 31, 2021			2			$	180.00
Granted			44			$	84.00
Vested			(15	)		$	91.60
Cancelled			(4	)		$	87.60
Non-vested shares as of December 31, 2022			27			$	82.40

Schedule of Table Summarizes Significant Ranges of Outstanding and Exercisable Options

The following table summarizes significant ranges of outstanding and exercisable options as of September 30, 2023 (in thousands, except contractual life and exercise price):

		Options Outstanding												Options Exercisable
						Weighted
						Average
						Remaining				Weighted								Weighted
						Contractual				Average								Average				Aggregate
		Number				Life				Exercise				Number				Exercise				Intrinsic
Range of Exercise Price		Outstanding				(in Years)				Price				Exercisable				Price				value
$62.80 - $599.60			36				278.00			$	105.20				26			$	103.60			$	—
$1,024.00 - $5,759.60			—				115.60			$	4,050.80				—			$	4,050.80			$	—
$5,760.00 - $16,399.60			—				116.00			$	5,760.00				—			$	5,760.00			$	—
$16,400.00 - $36,960.00			—				60.00			$	16,400.00				—			$	16,400.00			$	—
$62.80 - $36,960.00			36				277.20			$	122.80				26			$	127.60			$	—

The following table summarizes significant ranges of outstanding and exercisable options as of December 31, 2022 (in thousands, except contractual life and exercise price):

		Options Outstanding												Options Exercisable
						Weighted
						Average
						Remaining				Weighted								Weighted
						Contractual				Average								Average				Aggregate
		Number				Life				Exercise				Number				Exercise				Intrinsic
Range of Exercise Price		Outstanding				(in Years)				Price				Exercisable				Price				value
$62.80 - $599.60			37				305.60			$	106.00				22			$	102.80			$	—
$600.00 - $1,023.60			—				29.60			$	600.00				—			$	600.00			$	—
$1,024.00 - $5,759.60			—				66.80			$	2,000.00				—			$	2,000.00			$	—
$5,760.00 - $16,399.60			—				138.40			$	5,760.00				—			$	5,760.00			$	—
$16,400.00 - $36,960.00			—				67.60			$	16,400.00				—			$	16,400.00			$	—
$62.80 - $36,960.00			37							$	132.80				22			$	149.60			$	—

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration